Description
The Department of Veterans Affairs is seeking a potential qualified contractor to provide the radiopharmaceutical agent Pluvicto for the St. Louis VAMC. The contract will be for a 1-year period. The contractor will need to provide the Pluvicto agent, which is used for the treatment of adult patients with prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer. The contractor will need to have the necessary functional area expertise and experience to compete for this acquisition.
Some key points to consider:
• The contract is for a 1-year period
• The contractor will need to provide the Pluvicto agent
• The contractor will need to have the necessary functional area expertise and experience
• The contract is a total set-aside for Service-Disabled Veteran Owned Small Business firms
• The contractor will need to be registered in the System for Award Management (SAM) and have an active account